We tested the hypothesis that the mitochondrial form of superoxide dismutase (Mn-SOD) protects the cerebral vasculature. Basilar arteries (baseline diameter ~140 @m) from mice were isolated, cannulated and pressurized in order to measure vessel diameter. In arteries from C57BL6 mice preconstricted with U-46619, acetylcholine (Ach, an endothelium-dependent vasodilator) produced dilation that was similar in male and female mice and abolished by an inhibitor of nitric oxide synthase. Vasodilation to Ach was not altered in heterozygous male or female MnSOD deficient (+/-) mice compared to wild-type littermate controls (Mn-SOD +/+).
INTRODUCTION
Increasing evidence suggests that oxidative stress has diverse effects on vascular structure and function (8, 9, 15, 17) . The causes and impact of oxidative stress have become a major focus in studies of vascular biology. Among the key mechanisms to protect cells against oxidative stress and maintain redox homeostasis are the three isoforms of superoxide dismutase (SOD).
These isoforms are cytosolic or copper-zinc SOD (CuZn-SOD), manganese SOD (Mn-SOD) localized in mitochondria, and an extracellular form of CuZn-SOD (EC-SOD) (9) . Thus, these enzymes are compartmentalized in different subcellular regions. Previous work has demonstrated that CuZn-SOD inhibits increases in superoxide, protects endothelial function, and limits vasoconstrictor responses in the carotid artery and cerebral circulation (4-6).
The mitochondrial content of cerebral endothelium is greater than that in other cells (20) and endothelium appears to express higher levels of Mn-SOD than other portions of the vessel wall (1, 9) . Astrocytes can induce expression of Mn-SOD in cerebral endothelium (22, 23) .
Thus, the functional importance of Mn-SOD may differ along the vascular tree and potentially be more important in cerebral microvessels and in the metabolically active cerebral endothelium (the blood-brain barrier) (18) .
Using genetically-altered mice deficient in expression of Mn-SOD, the present study had several goals. First, we determined if deficiency in Mn-SOD produces endothelial dysfunction in cerebral arteries and brain microvessels. Second, were determined if vasoconstrictor response of cerebral arteries were enhanced in Mn-SOD deficient mice. Lastly, because vascular responses may vary with gender (12), we examined responses in both male and female JAP-00939-2005.R2 5 wild-type and Mn-SOD deficient mice. In these experiments we used Mn-SOD +/-mice because mice that are completely deficient in Mn-SOD (Mn-SOD -/-) die shortly after birth (21) . In addition, studies of Mn-SOD +/-mice may provide a better model for disease states or genetic polymorphisms in which activity of Mn-SOD is reduced, but not eliminated.
METHODS
Experimental animals. The animal protocol used in these experiments was reviewed and approved by the University of Iowa Animal Care and Use Committee. Mice for this study (8±1 mo of age) were derived from the breeding of Mn-SOD +/+ and +/-mice to generate the same genotypes within the same litter, thus providing littermate controls. Breeding pairs of mice used for these experiments were obtained from the Jackson Laboratories and have been backcrossed more than 10 generations to the C57BL6 background. Additional C57BL6 mice (2-3 mo old) were used in some studies (see below). Mice were fed regular chow and water was available ad libitum. Genotyping of mice was performed by PCR of DNA from tail biopsies as described previously (1) . MnSOD protein expression in aorta was performed using Western blotting as described previously in detail (1, 4, 5) .
Studies of cerebral arteries in vitro and cerebral arterioles in vivo.
After an overdose of anesthesia (pentobarbital, 150-200 mg/kg ip), the brain was rapidly removed and placed in icecold Krebs buffer. As described previously (12, 31) , the basilar artery was isolated using a dissecting microscope, cannulated onto glass micropipettes filled with Krebs buffer in an organ chamber, and secured with nylon monofilament. Arteries were pressurized to 60 mmHg. Using JAP-00939-2005.R2 6 a microscope and a video camera, vessel images were projected on a video monitor. An electronic dimension analyzer was then used to measure lumen diameter.
Once prepared, basilar arteries were allowed to equilibrate for at least 30 min at a distending pressure of 60 mmHg before protocols were initiated. We examined changes in diameter of the basilar artery in response to KCl (50 mM)(n = 22 Mn-SOD +/+; 16 Mn-SOD +/-mice) and cumulative doses of the thromboxane A 2 mimetic U-46619 (n = 16 Mn-SOD +/+; 11 Mn-SOD +/-mice) and arginine vasopressin (n = 13 Mn-SOD +/+; 15 Mn-SOD +/-mice). In a subgroup of Mn-SOD +/-mice (n = 5 Mn-SOD), the effects of Tempol (1 mM, a scavenger of superoxide) was used to examine a mechanism that may contribute to enhanced vasoconstrictor responses.
For studies in which acetylcholine or other vasodilators were used, basilar arteries were constricted by approximately 30% (~60% of the response to 50 mM KCl) with U-46619.
Acetylcholine is an endothelium-dependent agonist (10) and thus was used to examine endothelial function. After development of a stable baseline diameter, cumulative doseresponse curves were obtained.
NO is known to mediate dilation of cerebral arteries in response to acetylcholine in several species including humans (10) . To determine if responses to acetylcholine are also NOmediated in the basilar artery of mice, we performed studies using C57BL6 mice and an For studies in vivo, mice were anesthetized with pentobarbital sodium (75-90 mg/kg ip), supplemented regularly at approximately 20 mg/kg/h. Animals were ventilated mechanically with supplemental oxygen, and arterial blood pressure and blood gases were monitored as described previously (7, 11, 24, 31) . A cranial window was made over the left parietal cortex, the window constantly suffused with artificial CSF, and a pial arteriole (branches of the middle cerebral artery) was exposed. Arteriolar diameter was measured using a microscope equipped with a TV camera coupled to a video monitor and an image-shearing device. The diameter of one arteriole per animal was measured under control conditions and during topical application of drugs. Arterial pressure was similar in the two groups of mice and averaged 75±2 and 79±2 mmHg (mean ± SE) in Mn-SOD +/+ and +/-mice, respectively.
Arterial blood gases were monitored and were also similar (PCO 2 = 35±1 mmHg, PO 2 = 163±9 mmHg, and pH = 7.32±0.017). The gases and pH of the artificial CSF were PCO 2 = 41±1 mmHg, PO 2 = 87±5 mmHg, and pH = 7.30±0.01. In these studies, responses of arterioles to topical application of acetylcholine (1 and 10 @M) and nitroprusside (an endothelium-independent vasodilator, 0.1 and 1 @M) were examined. In a subgroup of the mice (n=7 of each genotype), Tempol was used to examine a mechanism that may contribute to impaired endothelial responses. Under normal conditions, the mitochondrial electron transport chain is a major source of superoxide, converting up to perhaps 5% of molecular oxygen to superoxide (21) . Because of its subcellular localization, Mn-SOD represents a major defense mechanism against oxidative stress (21, 27) . Using genetically-altered mice, recent studies have demonstrated that Mn-SOD +/-mice exhibit increased cell dysfunction and cell death in models of ischemia and brain injury (27) .
It has been shown that levels of Mn-SOD protein are approximately 50% of normal in the vasculature (aorta and mesenteric arteries) of Mn-SOD +/-mice (1, 32) . These findings are expected based on the fact that levels of mRNA are almost always at 50% of JAP-00939-2005.R2 11 normal in genetically altered mice with heterozygous gene deficiency (28) . Previous studies have found that this level of Mn-SOD deficiency does not alter relaxation of the aorta to acetylcholine (1, 3) . In the present study, we found that responses to acetylcholine are normal in the basilar artery in Mn-SOD +/-mice. Although these findings suggest that endothelial function is normal in cerebral arteries in Mn-SOD +/-mice under control conditions, we speculate that deficiency in Mn-SOD may predispose the vessels to endothelial dysfunction under conditions that promote oxidative stress. This hypothesis would be consistent with finding that mice with combined hypercholesterolemia and Mn-SOD deficiency exhibit enhanced vascular mitochondrial injury and atherosclerosis (2) .
In the present experiments, Mn-SOD +/-mice were used because mice that are completely deficient in Mn-SOD (Mn-SOD -/-) die shortly after birth (21) . We recognize that gene targeted models may potentially express compensatory mechanisms that could affect their overall phenotype (13) . In this regard, it is noteworthy that deficiency in Mn-SOD does not result in compensatory vascular expression by the remaining SOD isoforms (9, 32) .
In contrast to the basilar artery, we obtained evidence for superoxide-mediated endothelial dysfunction in cerebral arterioles of Mn-SOD +/-mice. It is not clear why dysfunction was detected in cerebral arterioles, but not in cerebral arteries in these mice.
Based on current concepts regarding mRNA levels in mice lacking one copy of a gene (28) and data that expression of Mn-SOD is reduced in aorta and mesenteric arteries of Mn-SOD +/-mice (1, 32) , it seems likely that levels of Mn-SOD would be reduced to a similar extent in both types of blood vessels. We have considered the possibility that methodological differences might account for these observations but feel that such an explanation is unlikely. In previous studies using the same methods but with mice expressing other genetic manipulations, we have observed a similar phenotype in cerebral arterioles and the basilar artery (31) . In contrast to the current findings with Mn-SOD, endothelial dysfunction was observed in both cerebral arterioles (4) 
